Age-related muscle loss is one of the main char--cally inactive people, although it also affects those who have been active throughout their lifetime, 1 this indicating that while the modern sedentary lifestyle is contributive to this phenomenon, it is not the only grow old: apart from the aforementioned increasing tendency towards a sedentary lifestyle, there are changes in hormone levels and in the body's protein demands as well as the unavoidable degeneration 2 SEEKING A DEFINITION OF SARCOPENIA Sarcopenia, an age-related loss of muscle mass and power, has recently been recognized as a disth edition of the ICD-10 (the International Statistical Classification of Diseases and Related Health Problems), in the categories "muscle wasting and atrophy not elsewhere constituted an important step towards the recognition of sarcopenia as a disease and, what is more, it is expected to increase the availability of diagnostic methods (diagnostic lab tests and trials) and to
INTRODUCTION
Over the last few decades, worldwide average life expectancy has grown significantly and therefore the percentage of the elderly has correspondingly much interest on the latter age group and their health th century, the typical elderly patient was a person with an acute or chronic disease the 21 st century older patient's profile is characterized by considerable comorbidity, including a great number of chronic conditions with frequent acute episodes, Accordingly, while the health system once focused on treating exclusively the disease, it nowadays needs to 1 motivate the pharmaceutical companies to develop 3 Despite its recognition as a disease, sarcopenia does not as yet constitute adequate indication for therapeutic intervention; thus, interest is focused on the circumstances and the condition under which such organizations as the FDA (Food and Drug Administration) could consider sarcopenia as an indication 4 Irwin Rosenberg, who coined the term 'sarcopenia' in 1989, meticulously investigated the disorder, particularly stressing the importance of loss of muscle sarcopenia as the observed age-related decrease in muscle mass and the decrease of muscle strength and -tion has been steadily improved since 1989 as well as since the first Sarcopenia Workshop which took place in 1994 organized by the National Ageing Research both the loss of muscle function (muscle power) and the loss of muscle quality (muscle strength/muscle mass unit), in other words, the increasing inability of muscle tissue to generate force in addition to the whether the loss of muscle function in the elderly walking in the street, carrying weights) is mainly the result of a decrease in muscle mass or a deterioration 5 Generally speaking, low muscle mass is common among the elderly and numerous studies have been Certain studies have examined the frequency of the disease among the population (male and female) of and others populations of Europe and Asia (INCHIvaried, with the estimated prevalence ranging from -that until recently an articulate mutual definition of sarcopenia had not been found and that the criteria of participation and elimination are likely to have been different in each study brings into question the credibility of the results and limits the possibility of of sarcopenia was dramatically increased along with 6 It is nevertheless well established that with advancing age, muscle mass and power deteriorate and their decline below a certain level 7 Moreover, it has been observed that patients suffering from both sarcopenia and osteoporosis were at a greater risk of falls, therefore the incidence of 8 It is thus evident that the treatment of sarcopenia will considerably improve patients' wellbeing, especially if they are NHANES III (the National Health and Nutrition Examination Survey) has recorded the increasing -ever, in this study the description of sarcopenia was defined with no criteria other than muscle mass, whilst there is no information considering cachexia (due to other diseases), starvation (nutritional deficiency) 9 As far as the definition of sarcopenia is concerned, it is usually complicated by the fact that there is an overlap between the diseases/conditions cachexia, confusion, found even among specialists, is due to the fact that all the abovementioned lead to muscle loss that a clarification be made in clinical practice as different clinical and therapeutic treatment is required 10 The formulation of an accurate definition will enable achievement of a more accurate diagnosis and of better designed clinical studies so that a conclusion may be drawn regarding the adequacy of the present a very frequent problem among elders, there are a number of medical options, there is likewise a need for drugs and lifestyle changes for the improvement of Moreover, there are the financial costs that must be considered (incurred due to mobility impairment, the toxicity of some drug combinations, infections during hospitalization), the total exceeding the one of 11 Because of the lack of a consistent operational definition, different parameters have been assessed and a variety of testing methods have been used specifically, Baumgartner et al defined the presence or absence of sarcopenia according to muscle mass (ASM-appendicular skeletal muscle mass) measured -fering from sarcopenia whose ratio ASM/height 2 was less than 2 standard deviation (SD) compared to the diagnostic method: however, it is not available in all health systems and, moreover, it does not evaluate 12 The European Working Group on Sarcopenia in Older People (EWGSOP) and the International Sarcopenia Consensus Conference Working Group (ISCCWG) have pointed to the growing prevalence of the disease and have reviewed the scientific facts and the literature with regard to therapeutic interven-13 EWGSOP defined sarcopenia as the syndrome characterized by a progressive and, eventually, total loss of skeletal muscle mass and strength, this being additionally associated with the risk of bodily and mental impairment, poor quality of life and early -copenia: low muscle mass + low muscle strength and low physical performance (decreased functionality) 8 -impedance Analysis) and tests including grasping dynamometry and walking speed (gait speed test) or the SPPB test (Short Physical Performance Battery), the EWGSOP recommended that diagnosis be based on low muscle mass + low muscle function standard deviation (SD) compared to the expected normal value for the average young adult had sarcoit additionally provided information about muscle according to the cause, into primary (or age-related) and secondary (when one or more non-age-related has been further subdivided into sarcopenia related low everyday/habitual physical activity, sedentary Figure 2. The European Working Group on Sarcopenia in Older failure, inflammatory diseases, malignancy, endocrinopathy) and lastly, nutrition (less-than-optimal diet, malabsorption, gastrointestinal disorders, drugThe ISCCWG's definition of sarcopenia was based meeting in Rome, ISCCWG published a Consensus that sarcopenia should be evaluated in older adults with clinically observed declines in physical functioning, activities of daily living, strength and health status, and those experiencing recurrent falls, recent weight loss, hospitalization or chronic conditions associated 14 acute and chronic comorbidities leading to decreased physical activity and often to periods of prolonged immobilization and an age-and/or disease-related increased production of proinflammatory cytokines 15 As a person ages changes take place in their protein metabolism since ageing affects systemic factors and hormones that are involved in the construction and patients the observed decreased effectiveness of GH (growth hormone), IGF-1 (insulin-like growth factor-1) and insulin together with the concurrent increased activity of cytokines, catabolic hormone cortisol and myostatin adversely affect and inhibit protein the myosatellite cells (precursors to skeletal muscle cells) and inhibits their growth and differentiation to 16 The importance of muscle tissue for optimal functioning of the body is, from the biochemical point of 17 The muscle system is the body's largest storage depot for protein, which in such conditions as stress and malnutrition furnishes constant amino acid supplementation so that protein synthesis may of glucose is stored in skeletal muscles, decreased muscle mass plays a major role in the disordered glucose metabolism of patients with insulin intolerthat skeletal muscle is the highest consumer of energy (chemical energy), thus positively contributing to basal metabolic rate (BMR), muscle loss in the elderly is the main cause of age-related decreased BMR and low muscle mass and functionality and pathological glucose tolerance was reported in a publication by Hedman et al which showed that the association between the muscle fiber synthesis and glucose sen-18 It a major role in regulating glucose homeostasis, with intracellular glucose transport being triggered by care must be exercised with regard to identifying the mechanisms that cause loss of strength in the 
PATHOPHYSIOLOGY OF PRIMARY (AGE-RELATED) SARCOPENIA
The pathophysiology of sarcopenia in the elderly is complex with a plethora of internal and external -gards internal processes, the most important factors are the decrease of anabolic hormones (testosterone, estrogens, growth hormone, etc), the increased apoptotic activity of muscle fibers, the increase in preinflammatory cytokines (TNF-a, IL-6), oxidative stress due to accumulation of reactive oxygen radicals, the change in mitochondrial activity in muscle cells and related to low functionality in the elderly include an insufficient intake of dietary protein resulting in loss of muscle mass and function, vitamin D deficiency, lifestyle and at the same time have circulation and respiratory problems though also presenting "normal" mechanical muscle strength are probably suffering there are thought to be patients who are being treated as diabetics but who are actually suffering from an undisclosed muscle disorder 17 to the denervation of the fast twitch motor units, that include type II muscle fibers and, to a smaller degree, After denervation, the muscle fibers can be recruited from the remaining motor units, at the same time changing their type, according to the muscle fiber As a result, some denervated type II muscle fibers (which, when contracted, produce great power but for a short time) are turned into type I muscle fibers (which produce a smaller amount of power but last content in type I muscle fibers increases, while the number and mass of type II muscle fibers decreases (due to atrophy), which leads to a significant reduction In elderly patients with sarcopenia, no recruitment takes place following muscle fiber denervation, which causes an even greater loss of motor muscle units, 16 Another change that comes with age is related to the elasticity of the tendon, as the weakest link in the chain, is the final regulator of all the region's strength connections in body movement since they transmit force between -tions in movement are intimately bound up with the tendon's mechanical properties, which, together with tendon elasticity with advancing age thus induces a 16, 19 
DIAGNOSIS OF SARCOPENIA
Regarding the diagnosis of sarcopenia, it must be specified, in accordance with the definition and using adequate measurements and tests, whether there is a loss of muscle mass, a decrease of muscle power or a 8 Determination of muscle mass can be made using anthropometric methods (height, weight and other body measurements), which are technically easy to biological methods may be used (creatinine secretion, whole body potassium using radioisotope 40 K), which -aging methods can be used (MRI, CT-scan) which, despite their high cost, the difficulty in performing them and the small exposure to radiation, provide body composition and determination of muscle mass percentage can be achieved using surface electrodes and via the bio-impedancemetry method, which is of sarcopenia, measurement of appendicular muscle four limbs, needs to be taken 20 -dicular lean soft tissue (ALST), which is a fat and bone mineral-free tissue including muscle and other components such as skin, tendons and connective tis-- In the Rosetta study examining the frequency of sarcopenia in an elderly population in New Mexico the diagnosis of sarcopenia was based on the skeletal muscle mass index (SMI), which is the ASM to the height 2 ratio (SMI=ASM/height 2 , counting units: kg/ m 2 SMI values which were less than 2 standard deviations (SD) below the mean value of a young population's kg/m 2 2 to diagnose sarcopenia was similar to that used for superficial bone density (gr/cm 2 (gold standard for the diagnosis of osteoporosis) is defined by the T-score, the number of standard deviations of the patient's value in comparison to mean bone density value of a normal young adult of the a diagnosis of sarcopenia, muscle mass is measured
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For the purpose of determining the quantitative relationship between muscle mass and disability (decreased physical performance and functionality), Janssen et al studied 4,449 individuals who participated sarcopenia they came to the following conclusions: 9 However, they found an increased physical disThe increased physical disability risk in women with very high SMI values may have in part reflected the mass is an independent predictor of physical dis-2 ) than in women with moderately high 2 9
To conclude, using the SMI to define sarcopenia has some significant advantages, including that it is every center, the definition of the threshold criteria which often differ, not taking into account the person's body weight and whether they are thin or obese (for example, thin people may have a low muscle mass without having any mobility limitations, while obese persons with generally a high muscle mass, but still lower in comparison to their body weight, may experience mobility limitations) and, finally, the fact that while focusing on muscle mass, a crucial parameter for the definition of sarcopenia, it does not take into consideration the strength that is produced per muscle mass unit and which differs greatly between the two On the other hand, it has been shown that apart from muscle mass (especially of the low limbs), muscle power independently defines the degree of motor related, as a strong connection between lower limb strength and power depend on multiple factors and thus additionally demand good functioning of the cerebral motor cortex, an intact spinal cord, normal conduction of electrical impulses, normal muscle mass and muscle tissue architecture, low density of myocytes in fatty acids and a normal stimulation-
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The next step in the diagnostic procedure is the use of tests that evaluate physical performance or 23 To assess physical performance, some tests are used such as the chair stand test (sitting-rising test), the walk test (walking test), the functional reach test (achievable Another test to evaluate static and dynamic balance the patient stands up from the chair, walks 3 meters, turns round, walks back to the chair and sits moves, such as rising, walking, turning and sitting but not walking over an obstacle, which can cause In general, some of the tests and measurements that can reveal limitations in functionality and physical activity caused by sarcopenia are the following: knee extension isometric torque, grasping power, lower limb muscle strength, 4-and 6-minute walking tests, the Short Physical Performance Battery (SPPB) that scores walking and balancing performance, the rising The measurement of muscle power can be made with isometric methods, although these are static measurements, as they do not reproduce normal movement, or with isokinetic methods, which have the limitation of making the movement at specific angular velocities, When measuring performance, the movements must be described by terms that include force, velocity Every movement is caused by the action of a force at some time, thus it should be measured as Power (W) (force x distance = work, work/time and force 24 Two tests, jumping mechanography and rising Jumping mechanography can be used in very frail evaluation of muscle quality is made with measurements that evaluate muscle mass and functionality and includes definition of muscle mass and assessment of functionality through a series of tests such as grip These tests, designed to identify patients with motor problems (and presenting some small differences in sensitivity and specificity), can be easily performed in the clinical setting, while they are also readily available Nevertheless, their validity is limited due to the fact that the normal threshold is not strictly defined and the patient's performance depends on such factors as motivation, will and pain (for example, a patient with osteoarthritis), and not only on muscle mass, 25 In order to complete a patient's investigation their biochemical profile needs to be assessed, including inflammatory markers (CRP, interleukin-6, TNF-a), clinical-pathological markers (hemoglobin, albumin, urine creatinine), hormone levels (testosterone, insulin-
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PREVENTION-TREATMENT-REHABILITATION: BASIC PRINCIPLES AND FUTURE TARGETS
Nutrition
One of the interventions for the prevention and responsible for numerous health problems, one of have reduced food intake and therefore are vulner-27,28 Especially for someone who already suffers from sarcopenia, malnutrition can cause protein deficiency, further worsening the loss 29 Meanwhile, a 3-year study showed that protein intake maintained muscle mass in daily dietary protein intake at the time of this study 30 It has in addition been found that diets rich in acid-producing foods (such as meat and cereal grains) and poor in food that do not produce acid (fruit and   31 The above diet deficiencies in conjunction with the fact that the elderly tend to take in less calories in general can lead to severe protein deficits as well as It has in general been shown that adequate food intake in elderly people protects them from sarcopenia, also that older adults are likely to need more protein per kilogram than young people in order to preserve adequate protein levels that support muscle mass 
Physical Activity
The contribution of exercise, especially resistance exercise (or strengthening exercise), in the prevention -ance exercises positively impact the neuromuscular system, protein synthesis and the hormones, which Studies have shown that after a resistance exercise program, the triggering of the motor neurons and of protein synthesis (both essential to build muscle 36, 37 These changes indicate that the redevelopment of muscle mass is More specifically, resistance exercise is considered to be a type of "strength" training increases maximum strength since persistent training is thought to enable However, taking the physical laws into consideration, be lifted in 1 min, the energy that must be produced place in 1 sec, the result is an average power of 1000 physics, exercises using weights are intended for
Aerobic exercise also appears to help fight sarcoincrease protein synthesis, an important function for preservation of muscle mass and strength in the 37 Of note, though certainly physical activity improves and even prevents sarcopenia, this must be
Drugs
There is an attempt to design medications to both prevent and treat sarcopenia and indeed numerous pharmaceutical drugs have been tested in various Theoretically, the ideal drug should be able to achieve increase of muscle and bone tissue mass while is being investigated for its effect on muscle tissue mass is myostatin (GDF-8-growth differentiation fac-38 Myostatin is produced by myocytes and acts on the autocrine function of muscle cells to inhibit their growth and differentiation, thereby inhibiting -tions in the myostatin gene that lead to the inability to produce functioning myostatin and animals treated with substances that block the activity of this protein have significantly more muscle mass (for example, receptor (activin receptor type IIB) and modifies the metabolic activity and homeostasis of the muscle 39 In patients with cachexia due to chronic disease, cancer or acquired immunodeficiency syndrome, increased myostatin levels have been found which is probably responsiis generally known that myostatin levels are related not only to muscle mass but also to functional muscle myostatin is decreased during exercise and is related to the type of exercise (resistance exercise > endurance exercise), the intensity (light resistance does not modify it, while medium resistance does), as well as the person's potential (inactive individuals tend 38 ACE-031, a recombined protein that was made from the extracellular part of the ARIIB receptor combined with the Fc region of human immunoglobin IgG1, which acts as a strong myostatin inhibitor, was used during a double blind placebo control study in well tolerated (with a rash as the only adverse effect), and it achieved a statistically significant increase in muscle mass, while at the same time it improved bone 40 The anabolic hormone testosterone increased muscle mass, power, force and function; however, it caused water retention, an increase in hematocrit, short-term worsening of sleep apnea and an increase in the frequency of cardiovascular accidents, while it also appear to be dangerous in cases of prostatic (SARMs) have succeeded in augmenting muscle mass with in addition a slight increase in muscle power, other studies, the use of growth hormone was related to a positive nitrogen (N) balance and to increase of muscle mass; on the other hand, the patients developed joint pain, muscle pain, edema, carpal tunnel that increases appetite) agonists have been shown to augment muscle mass, however with adverse effects -timyostatin antibodies appeared to increase fat-free muscle mass (lean body mass) and grip strength, though the following adverse effects were concurrently reported: allergic urticaria, aseptic meningitis, type IIR receptor antagonists, there was an increase of muscle volume, as measured in the thigh, of muscle mass and of the distance a person could walk in 6 minutes, while the adverse effects included acne -dropril, an angiotensin-converting-enzyme inhibitor, increased the distance that the patient could walk and decreased hip fracture frequency, although it caused hypotension, hyperkalemia, muscle cramps and numbPindolol, a non-selective beta blocker (antagonist) was able to preserve muscle mass and increased grip strength in the elderly, and Tirasemtiv, which seemed 41 Janssen I, Heymsfield SB, Ross R, 2002 Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical 2012 The complexity of treating wasting in ambulatory rehabilitation: Is it starvation, sarcopenia, cachexia or a 
